Harvard Bioscience (HBIO) Gross Profit Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 18.71% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -1.22% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 5.33% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 12.98% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 4.15% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -1.19% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 8.05% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 3.69% |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn | -12.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.61% |
| Dec 31, 2025 | -3.63% |
| Sep 30, 2025 | -0.42% |
| Jun 30, 2025 | -11.50% |
| Mar 31, 2025 | -9.02% |
| Dec 31, 2024 | -10.53% |
| Sep 30, 2024 | -7.84% |
| Jun 30, 2024 | -6.85% |
| Mar 31, 2024 | -1.44% |
| Dec 31, 2023 | -2.67% |
| Sep 30, 2023 | 2.95% |
| Jun 30, 2023 | 6.36% |
| Mar 31, 2023 | 12.22% |
| Dec 31, 2022 | -2.79% |
| Sep 30, 2022 | -6.68% |
| Jun 30, 2022 | 1.41% |
| Mar 31, 2022 | 0.05% |
| Dec 31, 2021 | 1.44% |
| Sep 30, 2021 | 1.02% |
| Jun 30, 2021 | 2.12% |